ApprovalTrail

Approval · Notice of Compliance 579 · 2002

HEXTEND: Notice of Compliance 579

Issued July 8, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
579
Date
July 8, 2002
Company
Biotime IncAlameda, California, United States
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)
Therapeutic class
Plasma volume expander

Products in this notice

BrandDINStatus today
HEXTEND02246024Cancelled Post Market

Medicinal ingredients